Editorial
Cancer nanobiotechnolgy
Pages (735–737)
Review
Therapeutic gene editing: delivery and regulatory perspectives
Pages (738–753)
Open
Engineering exosomes as refined biological nanoplatforms for drug delivery
Pages (754–763)
Open
Conjugated polymer nanomaterials for theranostics
Pages (764–781)
Open
Original Article
Two birds, one stone: dual targeting of the cancer cell surface and subcellular mitochondria by the galectin-3-binding peptide G3-C12
Pages (806–822)
Open
Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier
Pages (823–834)
Open
Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice
Pages (835–847)
Open
Self-assembled nanocomplex between polymerized phenylboronic acid and doxorubicin for efficient tumor-targeted chemotherapy
Pages (848–858)
Open
Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy
Pages (885–896)
Molecular tumor targeting of gelonin by fusion with F3 peptide
Pages (897–906)
positron emission tomography; titanium-45; intrinsic radiolabeling; mesoporous silica nanoparticle; tumor targeting; 4T1 murine breast tumor
Pages (907–913)
Engineering of a self-adjuvanted iTEP-delivered CTL vaccine
Pages (914–923)
A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer
Pages (931–942)
